Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (1625)	11/7/1998 8:10:00 PM
From: Rudy Saucillo	Respond to of 2742

<<Actually over the past year or two, one pattern has been repeated many times. Buying this stock on dips (20 cents or better) and selling on any sort of news that spikes the stock and volume has been wise.>> rkrw, I agree 100%. This is what I've done, to a large extent, over the past year. I was a seller - at a slight profit - this past week. You can blame me for moving the bid from 28 to 22! =:-0 Rudy

To: rkrw who wrote (1625)	11/9/1998 1:25:00 PM
From: Dr. John M. de Castro	Read Replies (3) \| Respond to of 2742

rkrw, I'd appreciate it if you would explain your reasoning here. >> The only problem I see in a reverse split (taking the 1 for 20 >> suggestion) is that it will leave little more than 1M shares >> outstanding. With that low a share count, liquidity will likely be >> even worse. The dollar value of the stock (MV) would be the same. But, the bid-ask spread would be smaller. Wouldn't that improve liquidity? In any case, IMHO, the advantages of having CIST listed on the NASDAQ would outweigh any small problem brought about by the split. John de C